Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis
NCT07781722Phase 4Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Amsterdam University Medical Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT07781722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781722.